TrialThe Journal of antimicrobial chemotherapy2023

Bronchopulmonary disposition of IV cefepime/taniborbactam (2-0.5 g) administered over 2 h in healthy adult subjects.

Tomefa E Asempa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.